Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy
Ma, Dennis, Gilbert, Tyler, Pignanelli, Christopher, Tarade, Daniel, Noel, Megan, Mansour, Fadi, Gupta, Manika, Ma, Sabrina, Ropat, Jesse, Curran, Colin, Vshyvenko, Sergey, Hudlicky, Tomas, Pandey, SiLanguage:
english
Journal:
The FASEB Journal
DOI:
10.1096/fj.201700275r
Date:
September, 2017
File:
PDF, 3.13 MB
english, 2017